NewAmsterdam Pharma Company N.V. (NAMS) Total assets 2022–2025
NewAmsterdam Pharma Company N.V. (NAMS) total assets at each fiscal year-end, per SEC filings.
$769.3MFY2025 · since FY2022: $478.5M → $769.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $769.3M | -11.0% |
| FY2024 | $864.6M | +149.1% |
| FY2023 | $347.1M | -27.5% |
| FY2022 | $478.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NAMS financial trends
NAMS RevenueNAMS Net incomeNAMS Net marginNAMS Gross profitNAMS Gross marginNAMS Operating incomeNAMS Operating marginNAMS Operating cash flowNAMS Free cash flowNAMS Capital expendituresNAMS Return on equityNAMS Stock buybacksNAMS Dividends paidNAMS Total liabilitiesNAMS Shareholders’ equityNAMS overview →